Patent · US Active

Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds for treating Adenoid Cystic Carcinoma

US12233072B2 · kind B2 · utility

0Cited by
3References
13Claims
0Family size

Assignee

Inventor

Key dates

Filing dateSep 27, 2019
Grant dateFeb 25, 2025
Priority date
Expiry dateSep 27, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D243/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods of treating or suppressing Adenoid Cystic Carcinoma (ACC) or inhibiting ACC tumor growth in subjects by administering compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds, including compounds of Formula (III) or prodrugs thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.